139 related articles for article (PubMed ID: 37473505)
1. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract][Full Text] [Related]
2. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.
Zhu Y; Wang L; Nong Y; Liang Y; Huang Z; Zhu P; Zhang Q
Cancer Manag Res; 2021; 13():8865-8878. PubMed ID: 34858060
[TBL] [Abstract][Full Text] [Related]
3. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
[TBL] [Abstract][Full Text] [Related]
4. UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.
Chen H; Zhang J; Zhou H; Zhu Y; Liang Y; Zhu P; Zhang Q
Front Oncol; 2022; 12():934145. PubMed ID: 35965551
[TBL] [Abstract][Full Text] [Related]
5. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
6. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
[TBL] [Abstract][Full Text] [Related]
7. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
8. Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome.
Gao Y; Li J; Fan S; Chen P; Huang M; Bi H
Front Endocrinol (Lausanne); 2022; 13():895116. PubMed ID: 35846297
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
10. Non-Targeted Serum Lipidomics Analysis and Potential Biomarkers of Laryngeal Cancer Based on UHPLC-QTOF-MS.
Wang H; Luo Y; Chen H; Hou H; Hu Q; Ji M
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36355170
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of the lipids phosphatidylcholine, 3-sn-phosphatidylethanolamine, sphingomyelin, and L-α-lysophosphatidylcholine extracted from the tissues of the invasive golden apple snail (Pomacea canaliculata) using UHPLC-ESI-MS/MS.
Wang J; Lu X; Zhang J; Xiao Z
Food Chem; 2021 May; 343():128427. PubMed ID: 33131959
[TBL] [Abstract][Full Text] [Related]
12. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics.
Merciai F; Musella S; Sommella E; Bertamino A; D'Ursi AM; Campiglia P
J Chromatogr A; 2022 Jun; 1673():463124. PubMed ID: 35567813
[TBL] [Abstract][Full Text] [Related]
14. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
Liu T; Tan Z; Yu J; Peng F; Guo J; Meng W; Chen Y; Rao T; Liu Z; Peng J
Expert Rev Proteomics; 2020 Mar; 17(3):233-242. PubMed ID: 32306783
[No Abstract] [Full Text] [Related]
15. Lipidomics Identified Lyso-Phosphatidylcholine and Phosphatidylethanolamine as Potential Biomarkers for Diagnosis of Laryngeal Cancer.
Yu B; Wang J
Front Oncol; 2021; 11():646779. PubMed ID: 34262857
[TBL] [Abstract][Full Text] [Related]
16. Untargeted lipidomics reveals specific lipid abnormalities in Sjögren's syndrome.
Lu J; Guo Y; Lu Y; Ji W; Lin L; Qian W; Chen W; Wang J; Lv X; Ke M; Kong D; Shen Q; Zhu Y; Liu P; Su J; Wang L; Li Y; Gao P; Shan J; Liu S
Rheumatology (Oxford); 2021 Mar; 60(3):1252-1259. PubMed ID: 32911538
[TBL] [Abstract][Full Text] [Related]
17. Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography-Mass Spectrometry.
Xuan Q; Hu C; Yu D; Wang L; Zhou Y; Zhao X; Li Q; Hou X; Xu G
Anal Chem; 2018 Jun; 90(12):7608-7616. PubMed ID: 29807422
[TBL] [Abstract][Full Text] [Related]
18. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
19. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
[TBL] [Abstract][Full Text] [Related]
20. Untargeted Plasma Lipidomics Reveal Perturbed Metabolites of Glycerophospholipids, and Sphingolipids in Moderate-to-Severe Acne.
Zhang D; Yu S; Ou Yang X; Wang X; Zhu Y; Xiao Z; Tan Y; Wu L; Li C
Clin Cosmet Investig Dermatol; 2023; 16():2189-2200. PubMed ID: 37588109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
